SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950123-15-003186
Filing Date
2015-02-17
Accepted
2015-02-17 18:53:19
Documents
1
Group Members
BLACKWELL PARTNERS LLCDUKE ENDOWMENTDUMAC, INC.EMPLOYEES RETIREMENT PLAN OF DUKE UNIVERSITYGOTHIC HSP

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d874283dsc13ga.htm SC 13G/A 114378
  Complete submission text file 0000950123-15-003186.txt   116011
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Subject) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-79091 | Film No.: 15625087
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DUMAC, LLC, 406 BLACKWELL STREET SUITE 300 DURHAM NC 27701
Business Address DUKE UNIVERSITY DURHAM NC 27708 (919) 668-9995
Duke University (Filed by) CIK: 0001439873 (see all company filings)

IRS No.: 560532129 | State of Incorp.: NC | Fiscal Year End: 0630
Type: SC 13G/A